The first clinical trial of a new kind of drug to cut the risk of cardiovascular disease has been found safe and effective at dropping levels of "bad" low density lipoprotein (LDL) cholesterol by as much as 40 percent. High LDL levels increase the risk for heart attack and stroke.
On December 14, UCSF Chancellor J. Michael Bishop, MD, announced that Professor David Kessler, MD, had left office as Dean of the UCSF School of Medicine and Vice Chancellor for Medical Affairs, and that Professor Sam Hawgood, MB, BS, had been named as Interim Dean of the UCSF School of Medicine.